The Business of Biologics: Calling Attention to Products Coming Off-Patent and Devising Forward-Thinking Portfolio Strategies for Maximizing Global Success

December 2, 2022 3:00pm

  • Identifying approved and marketed biologics coming off patent while looking ahead and considering clinical insights, pricing and dosages
  • Predicting what problems future competitors may run into with respect to their IP profiles
  • Forecasting which segments or regions will drive market growth
  • Reviewing key sustainability tactics adopted by leading market players
  • Evaluating the impact of off-patent drugs on competition and growth strategies
  • Developing techniques for an accurate assessment of the current value of your portfolio while